• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cox回归与参数模型:它们确定影响非小细胞肺癌患者生存因素的方式比较。

Cox Regression and Parametric Models: Comparison of How They Determine Factors Influencing Survival of Patients with Non-Small Cell Lung Carcinoma.

作者信息

Khaksar Elahe, Askarishahi Mohsen, Hekmatimoghaddam Seyedhossein, Vahedian-Ardakani Hassanali

机构信息

Department of Biostatistics and Epidemiology, School of Health, Shahid Sadoughi University of Medical Sciences, Safayeh, Yazd, Iran. Email:

出版信息

Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3389-3393. doi: 10.22034/APJCP.2017.18.12.3389.

DOI:10.22034/APJCP.2017.18.12.3389
PMID:29286608
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5980899/
Abstract

Background and objectives: The present study of survival rate of patients with non-small cell carcinoma (NSCLC) compared the efficiency of Cox semi-parametric vs. parametric models in determination of influencing factors. Methods: In this retrospective cohort study, data were gathered from 190 patients with a confirmed diagnosis of NSCLC referred to Shahid Sadoughi and Shohadaye Kargar Hospitals in Yazd, Iran during 2005 to 2014. To identify and compare factors influencing the survival rate, a Cox semi-parametric model was fitted to the data. Data analysis was performed using the R software version R3.3.1, and the significance level was set at 0.05. Results: The average age was 64.5 years. About 40% of patients had stage 4 disease. The median survival was 8 months. After comparing the models, the more efficient was the log-normal distribution (AIC=889.3829), with which disease stage, type of therapy, and age were significant factors. Among the different types of therapy, chemotherapy and radiotherapy yielded higher survival rates, and increased age was associated with lower survival. Conclusion: The most efficient model was a log-normal model. Implementation of optimal therapies at early stages can improve the survival of patients.

摘要

背景与目的

本项关于非小细胞肺癌(NSCLC)患者生存率的研究比较了Cox半参数模型与参数模型在确定影响因素方面的效率。方法:在这项回顾性队列研究中,收集了2005年至2014年期间转诊至伊朗亚兹德的沙希德·萨杜基医院和绍哈达耶·卡尔加医院的190例确诊为NSCLC患者的数据。为了识别和比较影响生存率的因素,对数据拟合了Cox半参数模型。使用R软件版本R3.3.1进行数据分析,显著性水平设定为0.05。结果:平均年龄为64.5岁。约40%的患者患有IV期疾病。中位生存期为8个月。比较模型后,对数正态分布模型(AIC = 889.3829)效率更高,疾病分期、治疗类型和年龄是显著因素。在不同类型的治疗中,化疗和放疗的生存率更高,年龄增加与生存率降低相关。结论:最有效的模型是对数正态模型。早期实施最佳治疗可提高患者生存率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/9dca2ac7079b/APJCP-18-3389-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/f1ddfb8089fb/APJCP-18-3389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/23e2c8a21539/APJCP-18-3389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/d555ad831fc3/APJCP-18-3389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/9dca2ac7079b/APJCP-18-3389-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/f1ddfb8089fb/APJCP-18-3389-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/23e2c8a21539/APJCP-18-3389-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/d555ad831fc3/APJCP-18-3389-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcba/5980899/9dca2ac7079b/APJCP-18-3389-g004.jpg

相似文献

1
Cox Regression and Parametric Models: Comparison of How They Determine Factors Influencing Survival of Patients with Non-Small Cell Lung Carcinoma.Cox回归与参数模型:它们确定影响非小细胞肺癌患者生存因素的方式比较。
Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3389-3393. doi: 10.22034/APJCP.2017.18.12.3389.
2
Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.根据美国癌症联合委员会(AJCC)第7版分期系统,T4 N0-3期非小细胞肺癌患者的生存结果及预后因素
Asian Pac J Cancer Prev. 2014;15(6):2465-72. doi: 10.7314/apjcp.2014.15.6.2465.
3
Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.接受综合治疗的局部晚期非小细胞肺癌老年患者的治疗结果
Clin Lung Cancer. 2017 Jan;18(1):e21-e26. doi: 10.1016/j.cllc.2016.07.005. Epub 2016 Jul 22.
4
Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.加拿大不列颠哥伦比亚省基于人群的 III 期非小细胞肺癌治疗模式。
J Thorac Oncol. 2012 Jul;7(7):1155-63. doi: 10.1097/JTO.0b013e31824fea07.
5
Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.体能状态和吸烟状态是非小细胞肺癌生存的独立有利预后因素:对 26957 例非小细胞肺癌患者的综合分析。
J Thorac Oncol. 2010 May;5(5):620-30. doi: 10.1097/JTO.0b013e3181d2dcd9.
6
Improved survival associated with neoadjuvant chemoradiation in patients with clinical stage IIIA(N2) non-small-cell lung cancer.新辅助放化疗可改善 IIIA(N2)期非小细胞肺癌患者的生存。
J Thorac Oncol. 2013 Jul;8(7):915-22. doi: 10.1097/JTO.0b013e31828f68b4.
7
Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer.新辅助放化疗后局部晚期非小细胞肺癌的手术时机。
J Thorac Oncol. 2017 Feb;12(2):314-322. doi: 10.1016/j.jtho.2016.09.122. Epub 2016 Oct 5.
8
Risk Factors for Lung Cancer Mortality in a Referral Center.一家转诊中心肺癌死亡的风险因素
Asian Pac J Cancer Prev. 2016;17(6):2877-81.
9
Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.非小细胞肺癌(NSCLC)中的第二恶性肿瘤:常规临床实践中的患病率和总生存期(OS)。
J Cancer Res Clin Oncol. 2018 Oct;144(10):2059-2066. doi: 10.1007/s00432-018-2714-5. Epub 2018 Jul 30.
10
External Validation of a Survival Nomogram for Non-Small Cell Lung Cancer Using the National Cancer Database.使用国家癌症数据库对非小细胞肺癌生存列线图进行外部验证
Ann Surg Oncol. 2017 Jun;24(6):1459-1464. doi: 10.1245/s10434-017-5795-5. Epub 2017 Feb 6.

引用本文的文献

1
NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer.NUF2 是非小细胞肺癌的潜在免疫和预后标志物。
J Immunol Res. 2022 May 12;2022:1161931. doi: 10.1155/2022/1161931. eCollection 2022.
2
A three-mRNA status risk score has greater predictive ability compared with a lncRNA-based risk score for predicting prognosis in patients with hepatocellular carcinoma.与基于lncRNA的风险评分相比,三信使RNA状态风险评分在预测肝细胞癌患者预后方面具有更强的预测能力。
Oncol Lett. 2020 Oct;20(4):48. doi: 10.3892/ol.2020.11911. Epub 2020 Jul 24.
3
[Survival and prognostic factors of non-small-cell lung cancer among young people in central Tunisia].

本文引用的文献

1
Comparison of Cox Regression and Parametric Models: Application for Assessment of Survival of Pediatric Cases of Acute Leukemia in Southern Iran.Cox回归模型与参数模型的比较:在伊朗南部儿童急性白血病病例生存评估中的应用
Asian Pac J Cancer Prev. 2017 Apr 1;18(4):981-985. doi: 10.22034/APJCP.2017.18.4.981.
2
Comparison of Cox's Regression Model and Parametric Models in Evaluating the Prognostic Factors for Survival after Liver Transplantation in Shiraz during 2000-2012.2000 - 2012年设拉子地区肝移植术后生存预后因素评估中Cox回归模型与参数模型的比较
Int J Organ Transplant Med. 2015;6(3):119-25.
3
ABO blood types and cancer risk--a cohort study of 339,432 subjects in Taiwan.
[突尼斯中部年轻人中非小细胞肺癌的生存及预后因素]
Pan Afr Med J. 2020 Jan 23;35:19. doi: 10.11604/pamj.2020.35.19.21100. eCollection 2020.
ABO血型与癌症风险——一项对台湾339432名受试者的队列研究。
Cancer Epidemiol. 2015 Apr;39(2):150-6. doi: 10.1016/j.canep.2014.12.006. Epub 2015 Jan 16.
4
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
5
Smoking cessation in lung cancer-achievable and effective.肺癌患者戒烟:可行且有效。
Dtsch Arztebl Int. 2013 Oct;110(43):719-24. doi: 10.3238/arztebl.2013.0719. Epub 2013 Oct 25.
6
Role of gender in the survival of surgical patients with nonsmall cell lung cancer.性别在非小细胞肺癌手术患者生存中的作用。
Ann Thorac Med. 2013 Jul;8(3):142-7. doi: 10.4103/1817-1737.114297.
7
Sex as an independent prognostic factor in a population-based non-small cell lung cancer cohort.基于人群的非小细胞肺癌队列中,性别作为独立的预后因素。
Can Respir J. 2013 Jan-Feb;20(1):30-4. doi: 10.1155/2013/618691.
8
Survival of patients with non-small cell lung cancer without treatment: a systematic review and meta-analysis.未经治疗的非小细胞肺癌患者的生存:系统评价和荟萃分析。
Syst Rev. 2013 Feb 4;2:10. doi: 10.1186/2046-4053-2-10.
9
Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China.上海一项回顾性研究:ⅠB 期上叶非小细胞肺癌患者生存的预后因素。
Chin J Cancer Res. 2011 Dec;23(4):265-70. doi: 10.1007/s11670-011-0265-2.
10
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly.比较 5 种治疗策略在老年早期非小细胞肺癌中的疗效。
Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1060-70. doi: 10.1016/j.ijrobp.2012.07.2354. Epub 2012 Sep 11.